Blood derivative in-vitro diagnostic substances manufacturing · Massachusetts

NA facility

North Andover, MA · ~30 workers · 9 years of OSHA Injury Tracking Application data.

C
Average Safety Record
2.7
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

NA facility runs at 82% of its industry's injury rate - about level with the typical Blood derivative in-vitro diagnostic substances manufacturing workplace, earning a grade C.

NA facility: 2.7 TCR = 82% of Blood derivative in-vitro diagnostic substances manufacturing BLS 3.3 · 9y Form 300A (see methodology below)

NA facility safety composite

NA facility scores strongest on fatalities (safer than 50% of same-industry peers) and weakest on dart rate (safer than 8%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

F

23/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
F 2.71 per 100 workers

Safer than 19% of industry peers

DART rate
F 3.75 per 100 workers

Safer than 8% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Rising injury rate

NA facility: 0.0 → 7.5 TCR

Peak year 2024 @ 7.5 TCR · DART/TCR 1.38× in 2024

NA facility's TCR rose 7.5 from 0.0 in 2016 to 7.5 in 2024. In 2024, DART was 1.38× this establishment's average TCR (severity share of cases).

OSHA ITA Form 300A scorecard

Establishment book 325413 · North Andover, MA AT/BELOW-IND · SMALL

Grade C · TCR 2.7 · 82% of ind

  • DART 3.8 DART
  • RANK #13/13
  • PHOTO HDx-CA
  • BOOK 9y book
  • INJ 6 inj
  • SIZE ~30 FTE

Nearest TCR peer: HDx-CA (0.0 TCR gap)

Read with this employer → · Industry book → · Massachusetts employers → · Look up another →

NA facility in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows NA facility averages 2.7 TCR (82% of the Blood derivative in-vitro diagnostic substances manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

NA facility TCR series: 2016=0 · 2017=0 · 2018=0 · 2019=6.4 · 2020=3.2 · 2021=3.9 · 2022=0 · 2023=3.4 · 2024=7.5 · BLS 3.3

Where NA facility falls in its industry

201 Blood derivative in-vitro diag establishments

Safer than 19% of graded establishments in this industry, whose median TCR is 1.4.

More dangerous than peersSafer than peers

Narrower to Massachusetts alone (the establishments it most directly competes with for workers and contracts): ranked #13 safest of 13 Blood derivative in-vitro diag employers in Massachusetts.

NA facility (30 employees, TCR 2.7) among 29 same-industry peers, split at the industry median of 120 employees and a TCR of 1.4 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 02,0004,0006,000 01234 Average employees Total Case Rate NA facility
NA facility (30 employees, TCR 2.7) among 29 same-industry peers, split at the industry median of 120 employees and a TCR of 1.4

NA facility has fewer employees than the Blood derivative in-vitro diagnostic sub median and a higher injury rate than the industry's median TCR of 1.4. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 7.5 3.8 2 0 0
2023 3.4 0.0 1 0 0
2022 0.0 0.0 0 0 0
2021 3.9 3.9 1 0 0
2020 3.2 3.2 0 1 0
2019 6.4 6.4 2 0 0
2018 0.0 0.0 0 0 0
2017 0.0 0.0 0 0 0
2016 0.0 0.0 0 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325413 · MA · North Andover

201 Blood derivative in-vitro diagnostic substances manufacturing employers nationwide with a credible TCR · 10,108 rated employers in Massachusetts with headcount on file · 53 employers in North Andover, MA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR HDx-CA 2.7 TCR
NAICS-TCR Diasorin Molecular 2.7 TCR
NAICS-TCR Flex Buffalo Grove - 700 Building 2.7 TCR
NAICS-TCR EKF Diagnostics - Life Sciences 2.7 TCR
STATE-SIZE Best Bees Company 30 FTE
STATE-SIZE Eversource - Wareham 30 FTE
STATE-SIZE Kneeland 30 FTE
STATE-SIZE The Lagasse Group, LLC 30 FTE
CITY-NEAR Amazon.com Services LLC - BOS3 1,743 FTE
CITY-NEAR Market Basket #12 420 FTE
CITY-NEAR Edgewood Retirement Community, Inc. 287 FTE
CITY-NEAR Gourmet Specialty Foods, LLC 283 FTE
NAT-TCR EPCO 2.7 TCR
NAT-TCR Romo Inc 2.7 TCR
NAT-TCR Toyota Boshoku Tennessee, LLC 2.7 TCR
NAT-TCR LSE-SWIT-LEASING 2.7 TCR
NAT-SIZE Crown Cork & Seal USA, Inc. - Toledo Plant 30 FTE
NAT-SIZE American Excelsior Company Florence 30 FTE
NAT-SIZE Road 30 FTE
NAT-SIZE Shape Corp - 1835 Industrial Dr. 30 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.